Tag: drugs
COVID antibody drugs from Lilly and Regeneron won’t do much to...
When Eli Lilly won emergency use authorization for its COVID-19 antibody drug, bamlanivimab, earlier this week, beating Regeneron to the finish line in a...
Generics players join pledge to rapidly scale access to COVID-19 drugs....
As dozens of drugmakers work to create new or repurposed therapies for COVID-19, developing nations worry they will be last in line for supply...
Hey, Pfizer watchers, don’t forget Vyndaqel. The heart disease drug’s zooming...
All public attention for Pfizer these days is centered on its BioNTech-partnered COVID-19 vaccine. But while key phase 3 efficacy data for the experimental...
ESC: Pfizer, BMS’ Eliquis tops Xarelto, vitamin K drugs for site-specific...
Pfizer and Bristol Myers Squibb's anticoagulant superstar Eliquis has raced out to blockbuster sales in recent years and a big-time lead over its its...
Could Amgen test Enbrel or other anti-TNF drugs against COVID-19? CEO...
As Amgen ramps up a clinical trial of its psoriasis drug Otezla in COVID-19, the company’s scientists may be seriously considering whether another of...
Generic drugmakers thwarted competition on topical drugs, suit alleges
Attorneys general in most of the states, the District of Columbia and several territories have filed a lawsuit in federal court against more than...
Amgen, Adaptive to develop Covid-19 drugs using antibodies from recovered patients
One of the largest biotechnology companies in the country is tapping a longstanding partnership with another firm to develop treatments for Covid-19.
Thousand Oaks, California-based...
FDA gives emergency use authorization to malaria drugs for Covid-19
A pharmacy employee in Paris holds up a box of chloroquine
The Food and Drug Administration has granted an emergency use authorization to a drug...
